High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. (Q55057239)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. |
scientific article |
Statements
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. (English)
1 reference
1 reference
1 reference
Theo C Manschreck
1 reference
Donald C Goff
1 reference
Joseph P McEvoy
1 reference
Arnold W Mech
1 reference
Juan R Bustillo
1 reference
Roberto Gil
1 reference
Peter Buckley
1 reference
1 August 2013
1 reference
33
1 reference
4
1 reference
485-490
1 reference